Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9204095 | Surgical Neurology | 2005 | 4 Pages |
Abstract
These findings indicate that a significant rise in ET-1 levels in the CSF, but not in the plasma, occurs in patients who develop CVS after SAH. Our observation suggests that ET-1 might be involved in the pathogenesis of SAH-associated CVS.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Iruena Moraes MD, MSc, Yolanda Galindo PhD, Silene Paulino PhD, Antônio Santos MD, Franz Jooji MD, Paulo Andrade MD, PhD,